Found: 1
Select item for more details and to access through your institution.
Selinexor Sensitizes TRAIL-R2-Positive TNBC Cells to the Activity of TRAIL-R2xCD3 Bispecific Antibody.
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 10, p. 2231, doi. 10.3390/cells9102231
- By:
- Publication type:
- Article